Open Government Portal

About this information

Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.

The key things to remember about open data are:

  • #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
  • #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
  • #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
47731 records

The Public Health Agency of Canada (PHAC), in collaboration with all Canadian provinces and territories, conducts national surveillance of rheumatoid …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Public Health Agency of Canada
Formats: HTML PDF
Keywords: Rheumatoid arthritis Canada prevalence incidence mortality

Mental illness is characterized by changes in an individual’s thinking, mood, or behaviour and is usually associated with significant distress …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Public Health Agency of Canada
Formats: HTML PDF
Keywords: Mental illness Canada depressive order bopolar disorder anxiety disorder stress disorder schizophrenia eating disorders substance-related disorders

Parents, caregivers and children across the country are facing new challenges as the COVID-19 pandemic affects our daily work and …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Public Health Agency of Canada
Formats: HTML PDF
Keywords: COVID-19 Coronavirus parenting children

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic Interim Order notice explanatory note importation sale and advertising of drugs a significant risk to health safety or the environment guidance document to import sell and advertise drugs and vaccines a new authorization pathway ...

Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic drug and vaccine authorizations authorize the drug or vaccine for sale potential benefits and risks of a drug or vaccine health care practitioners and consumers benefits of the product potential risks

The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic testing devices antigen testing devices minimum values of sensitivity for COVID-19 antigen testing devices

Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The devices …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic reporting medical device shortages Interim Order manufacturers and importers list of Medical Devices notification of Shortages

This guidance document presents the criteria for safety and effectiveness that apply to test swabs used for COVID-19 sampling. It …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic testing devices test swabs sampling criteria for safety and effectiveness

Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic notice to industry regulatory considerations for importing or selling face shields PPE Class I medical devices reducing the risk of or preventing the user from infection authorized for sale or import

This document provides guidance for Canadian manufacturers on the minimum technical requirements for facepiece filtering respirators (FFR). Health Canada has …

Record Modified: Nov 4, 2020
Record Released: Nov 4, 2020
Publisher: Health Canada
Formats: HTML
Keywords: COVID-19 pandemic safety and performance respirators facepiece filtering respirators (FFR) guidance for Canadian manufacturers minimum technical requirements